The Brazilian police force is calling for President Jair Balsonaro's prosecution for allegedly spreading fake information about the COVID-19 virus and outbreak in the country.
A recent outbreak of the fungal infection Candida auris has Brazilian specialists warning clinicians to be on the lookout for infections, which they believe are underdiagnosed.
28-year-old volunteer in AstraZeneca COVID-19 vaccine trial dies The trial has not been paused as the volunteer did not receive the COVID-19 vaccine but was part of the control group.
, Managing Editor
A volunteer in AstraZeneca s COVID-19 vaccine trial has died, according to Brazilian National Health Surveillance Agency Anvisa, and reported by Reuters.
The volunteer was a 28-year-old physician who treated coronavirus patients in Rio de Janeiro, according to The Washington Post, citing Brazilian newspaper O Globo as its source.
The volunteer did not receive the COVID-19 vaccine, but was in the control group. Half the people in the clinical trial received the experimental vaccine, and the other half received an established meningitis vaccine. The volunteer is believed to have received the meningitis vaccine. The cause of death has not been released.
Update: Sinovac s COVID-19 vaccine effective in Brazil trials, though results release postponed
By Hu Yuwei, Leng Shumei and Xu Hailin Source: Global Times Published: 2020/12/23 20:09:52 Last Updated: 2020/12/23 23:21:26
Quality inspectors on Sinovac vaccine production lines use digital technology platforms to monitor the quality and efficiency of vaccine packaging on Sunday. Photos: Li Hao/GT
The government of São Paulo announced on Wednesday that CoronaVac is over 50 percent effective, but has again postponed the release of detailed data on the effectiveness of the vaccine developed by the Sao Paulo-based Butantan Institute in partnership with the Chinese pharmaceutical company Sinovac.
According to Dimas Covas, director of the Butantan Institute, the phase III study showed that the vaccine is effective.